You just read:

New Janssen Phase 3 Data in Patients With Moderately to Severely Active Rheumatoid Arthritis Shows Sirukumab Significantly Inhibited Radiographic Progression and Improves Signs and Symptoms Of Disease

News provided by

Janssen Research & Development, LLC

08 Jun, 2016, 12:48 BST